| Nome |
# |
|
Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson's disease, file e291c0d4-63a6-cddb-e053-3a05fe0aa144
|
486
|
|
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features, file e291c0d9-443e-cddb-e053-3a05fe0aa144
|
478
|
|
Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process, file e291c0d6-f4c7-cddb-e053-3a05fe0aa144
|
447
|
|
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study, file e291c0d7-6019-cddb-e053-3a05fe0aa144
|
376
|
|
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain, file e291c0d6-2a7c-cddb-e053-3a05fe0aa144
|
207
|
|
When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late-life depression, file e291c0d6-fc92-cddb-e053-3a05fe0aa144
|
187
|
|
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease, file e291c0d4-80f5-cddb-e053-3a05fe0aa144
|
183
|
|
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence, file e291c0d7-60c6-cddb-e053-3a05fe0aa144
|
155
|
|
Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson's Disease and Is Associated with Motor Symptom Severity, file e291c0d6-f44c-cddb-e053-3a05fe0aa144
|
118
|
|
Low Serum 25(OH)D Levels in Parkinson âÂÂs Disease; a Non Specific Marker of Neurodegeneration?, file e291c0d6-f8f0-cddb-e053-3a05fe0aa144
|
112
|
|
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease, file e291c0d6-fb0a-cddb-e053-3a05fe0aa144
|
83
|
|
Psychiatric profile of motor subtypes of de novo drug-naïve Parkinson's disease patients, file e291c0d7-5b93-cddb-e053-3a05fe0aa144
|
72
|
|
Association between hearing sensitivity and dopamine transporter availability in Parkinson's disease, file a131cd0b-9f0c-45b6-95f2-94e89b2e5e87
|
22
|
|
Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson's Disease and Is Associated with Motor Symptom Severity, file e291c0d6-fa0d-cddb-e053-3a05fe0aa144
|
10
|
|
Enhanced suppression of otoacoustic emissions by contralateral stimulation in Parkinson's disease, file a69b0fa1-8ea7-49cc-ae51-4e1b2baa2f28
|
5
|
|
Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson's disease: a preliminary evidence, file 7cd49f7b-d0c0-4158-af9f-edabff40b894
|
4
|
|
Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson’s Disease, file 753f763b-e016-412b-826b-0ec1e415a42b
|
3
|
|
Non-motor symptoms burden in motor-fluctuating patients with Parkinson's disease may be alleviated by safinamide: the VALE-SAFI study, file a7f46861-1306-4c9f-b99b-552ecda7e915
|
3
|
|
Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?, file b3b694e8-1aa2-4b46-8539-540a8187bfeb
|
3
|
|
Dysbiosis of gut microbiota in a selected population of Parkinson's patients, file e291c0d7-e91a-cddb-e053-3a05fe0aa144
|
3
|
|
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study., file e291c0d7-f105-cddb-e053-3a05fe0aa144
|
3
|
|
Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study, file eca48a74-acfb-405a-b7fa-de3c63ee8052
|
3
|
|
Prognostic Indicators and Outcomes of Hospitalised COVID-19 Patients with Neurological Disease: A Systematic Review and Individual Patient Data Meta-Analysis, file 1d4b781c-989d-4034-95f8-4304b6c8899c
|
2
|
|
Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study, file 3411208b-e683-4ab6-a1c5-bafcb6dd0060
|
2
|
|
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study, file 3f1bfc94-c4a8-440e-8b7d-e8c64c88e81c
|
2
|
|
STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson's Disease, file 6bad8a7c-d885-4ae6-a9f9-f92867d01667
|
2
|
|
Brainstem impairment in obstructive sleep apnoea and the effect of CPAP treatment: an electrophysiological blink reflex study, file a8697dfe-b871-4f1d-91d5-7e02dba6ad15
|
2
|
|
Sex hormones differentially contribute to Parkinson disease in males: A multimodal biomarker study, file bc494cd5-f41c-47d5-8ff3-658ed7503280
|
2
|
|
Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort, file c2bc056f-768f-431f-99c6-d76172e0954d
|
2
|
|
Intraoperative Local Field Potential Beta Power and Three-Dimensional Neuroimaging Mapping Predict Long-Term Clinical Response to Deep Brain Stimulation in Parkinson Disease: A Retrospective Study, file d500d4d2-8876-444f-a1a4-8ae8c8cbf83b
|
2
|
|
CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease, file e291c0d5-a3fb-cddb-e053-3a05fe0aa144
|
2
|
|
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease, file e291c0d6-f1cd-cddb-e053-3a05fe0aa144
|
2
|
|
Deep brain stimulation in Parkinson's disease patients: biochemical evidence, file e291c0d6-f453-cddb-e053-3a05fe0aa144
|
2
|
|
malattia di alzheimer e altre demenze diagnosi e terapia integrata., file e291c0d6-fc07-cddb-e053-3a05fe0aa144
|
2
|
|
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease, file e291c0d7-5a14-cddb-e053-3a05fe0aa144
|
2
|
|
Band-Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates, file 0727d882-a7b2-4a1c-b486-352c80cdbd73
|
1
|
|
Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis, file 3097b1f1-98b3-4ec2-a58b-35107c967a7f
|
1
|
|
Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson’s disease: a pilot study, file 646dd8bb-457a-41e2-a230-0e4051f20add
|
1
|
|
Parkinson's disease motor progression in relation to the timing of REM sleep behavior disorder presentation: an exploratory retrospective study, file 7140e8c9-6b21-4a45-a8bf-df51bb816dde
|
1
|
|
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease, file 97baea76-c727-4397-b90c-d49fc144de45
|
1
|
|
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson’s disease, file bc6e0407-4d66-4ebd-aba5-5cca451490fb
|
1
|
|
A biological characterization of patients with postmenopausal Parkinson's disease, file cd9a1778-350c-421e-baa3-483e23876741
|
1
|
|
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients., file e291c0d6-31db-cddb-e053-3a05fe0aa144
|
1
|
|
Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment, file e291c0d6-3ac0-cddb-e053-3a05fe0aa144
|
1
|
|
Involvement of Subcortical Brain Structures During Olfactory Stimulation in Multiple Chemical Sensitivity, file e291c0d6-f291-cddb-e053-3a05fe0aa144
|
1
|
|
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway', file e291c0d6-f2b7-cddb-e053-3a05fe0aa144
|
1
|
|
The visuo-cognitive and motor effect of amantadine in non-Caucasian patients with Parkinson's disease. A clinical and electrophysiological study, file e291c0d6-f36e-cddb-e053-3a05fe0aa144
|
1
|
|
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease, file e291c0d6-f6ca-cddb-e053-3a05fe0aa144
|
1
|
|
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study., file e291c0d6-f98b-cddb-e053-3a05fe0aa144
|
1
|
|
Dopaminergic involvement in a drummer with focal dystonia: A case study, file e291c0d6-f998-cddb-e053-3a05fe0aa144
|
1
|
|
123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study, file e291c0d6-fa59-cddb-e053-3a05fe0aa144
|
1
|
|
Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss?, file e291c0d6-fcf9-cddb-e053-3a05fe0aa144
|
1
|
|
Therapy for dyskinesias in Parkinson’s disease patients, file e291c0d6-fd87-cddb-e053-3a05fe0aa144
|
1
|
|
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients, file e291c0d6-fdb7-cddb-e053-3a05fe0aa144
|
1
|
|
Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients, file e291c0d6-ff32-cddb-e053-3a05fe0aa144
|
1
|
|
SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status, file e291c0d6-ff64-cddb-e053-3a05fe0aa144
|
1
|
|
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction?, file e291c0d7-5b91-cddb-e053-3a05fe0aa144
|
1
|
|
Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates, file e291c0d7-60c8-cddb-e053-3a05fe0aa144
|
1
|
|
Deep brain stimulation in Parkinson's disease patients and routine 6-OHDA
rodent models: Synergies and pitfalls., file e291c0d9-a013-cddb-e053-3a05fe0aa144
|
1
|
| Totale |
3.013 |